Basic Information
OXYCONTIN 20mg prolonged release tablets
TABLET, FILM COATED, EXTENDED RELEASE
Regulatory Information
SIN13078P
April 7, 2005
Prescription Only
Therapeutic
ORAL
August 10, 2023
May 30, 2025
XN02AA05
Company Information
Active Ingredients
Strength: 20mg
Detailed Information
Contraindications
**Contraindications** Hypersensitivity to opioids and to any of the constituents or in any situation where opioids are contraindicated, acute respiratory depression , cor pulmonale, cardiac arrhythmias, severe bronchial asthma, chronic obstructive airways disease, , elevated carbon dioxide levels in the blood, paralytic ileus, suspected surgical abdomen, acute abdomen, severe constipation, moderate to severe hepatic impairment, severe renal impairment (creatinine clearance < 10ml/min) ,delayed gastric emptying, acute alcoholism, brain tumor, increased cerebrospinal or intracranial pressure, head injury, severe CNS depression, convulsive disorders, delirium tremens, hypercarbia, concurrent administration of monoamine oxidase inhibitors or within 2 weeks of discontinuation of their use. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. Not recommended for pre-operative use or for the first 24 hours post-operatively. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Indication Information
**Indication** The management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.